Reetta Kalviainen

Summary

Affiliation: Kuopio University Hospital
Country: Finland

Publications

  1. ncbi Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    Epilepsy Res 25:291-7. 1996
  2. ncbi Status epilepticus treatment guidelines
    Reetta Kalviainen
    Department of Neurology, Kuopio Epilepsy Center, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 48:99-102. 2007
  3. ncbi Clinical picture of EPM1-Unverricht-Lundborg disease
    Reetta Kalviainen
    Kuopio Epilepsy Center, Department of Neurology, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 49:549-56. 2008
  4. ncbi Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency
    R Kalviainen
    Department of Neurology, Kuopio Epilepsy Center, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    Eur J Neurol 14:369-72. 2007
  5. ncbi Optimizing treatment of epilepsy during pregnancy
    Reetta Kalviainen
    Kuopio Epilepsy Center, Department of Neurology, University Hospital of Kuopio, Kuopio, Finland
    Neurology 67:S59-63. 2006
  6. ncbi Refractory generalised convulsive status epilepticus : a guide to treatment
    Reetta Kalviainen
    Department of Neurology, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    CNS Drugs 19:759-68. 2005
  7. ncbi Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    Neurology 53:922-6. 1999
  8. ncbi Visual field defects with vigabatrin: epidemiology and therapeutic implications
    R Kalviainen
    University Hospital of Kuopio and University of Kuopio, Finland
    CNS Drugs 15:217-30. 2001
  9. ncbi Do recurrent seizures cause neuronal damage? A series of studies with MRI volumetry in adults with partial epilepsy
    Reetta Kalviainen
    Department of Neurology, Kuopio University Hospital, University of Kuopio, Kuopio, Finland
    Prog Brain Res 135:279-95. 2002
  10. ncbi Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    J Intellect Disabil Res 42:63-7. 1998

Detail Information

Publications34

  1. ncbi Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    Epilepsy Res 25:291-7. 1996
    ..7 mg/day, range 30-80 mg/day) and after 18-24 months (mean dose 67.6 mg/day, range 24-80 mg/day). The daily dosages in the long-term follow-up of the present study are higher than in the previous reports...
  2. ncbi Status epilepticus treatment guidelines
    Reetta Kalviainen
    Department of Neurology, Kuopio Epilepsy Center, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 48:99-102. 2007
  3. ncbi Clinical picture of EPM1-Unverricht-Lundborg disease
    Reetta Kalviainen
    Kuopio Epilepsy Center, Department of Neurology, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 49:549-56. 2008
    ..EPM1 patients need lifelong clinical follow-up, including evaluation of the drug-treatment and comprehensive rehabilitation...
  4. ncbi Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency
    R Kalviainen
    Department of Neurology, Kuopio Epilepsy Center, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    Eur J Neurol 14:369-72. 2007
    ....
  5. ncbi Optimizing treatment of epilepsy during pregnancy
    Reetta Kalviainen
    Kuopio Epilepsy Center, Department of Neurology, University Hospital of Kuopio, Kuopio, Finland
    Neurology 67:S59-63. 2006
    ..With proper management before conception, during pregnancy, and after birth, the vast majority of pregnancies in women with active epilepsy will have a favorable outcome...
  6. ncbi Refractory generalised convulsive status epilepticus : a guide to treatment
    Reetta Kalviainen
    Department of Neurology, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
    CNS Drugs 19:759-68. 2005
    ....
  7. ncbi Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    Neurology 53:922-6. 1999
    ..To determine whether there is a causal link between vigabatrin treatment and concentric visual field defects and to evaluate the prevalence of these visual field constrictions...
  8. ncbi Visual field defects with vigabatrin: epidemiology and therapeutic implications
    R Kalviainen
    University Hospital of Kuopio and University of Kuopio, Finland
    CNS Drugs 15:217-30. 2001
    ....
  9. ncbi Do recurrent seizures cause neuronal damage? A series of studies with MRI volumetry in adults with partial epilepsy
    Reetta Kalviainen
    Department of Neurology, Kuopio University Hospital, University of Kuopio, Kuopio, Finland
    Prog Brain Res 135:279-95. 2002
    ..Future research should address strategies for disease-modifying therapies and ultimately remission of the epileptic process...
  10. ncbi Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy
    R Kalviainen
    Department of Neurology, University Hospital of Kuopio, Finland
    J Intellect Disabil Res 42:63-7. 1998
    ..The role of tiagabine in the management of partial epilepsy of patients with intellectual disability is especially emphasized since tiagabine has a low side-effect profile in the cognitive area...
  11. ncbi A woman with seven monotherapies
    Reetta Kalviainen
    Department of Neurology, Kuopio University Hospital, POB 1777, 70211 Kuopio, Finland
    Epilepsy Behav 4:S8-11. 2003
  12. ncbi Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies
    Marja Äikiä
    Kuopio Epilepsy Center, Kuopio, Finland
    Epilepsia 47:1121-7. 2006
    ..Tiagabine (TGB) is indicated as adjunctive therapy for the treatment of partial seizures. The cognitive effects of TGB and carbamazepine (CBZ) monotherapy were evaluated in adult epilepsy patients with partial seizures...
  13. ncbi Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy
    Marja Äikiä
    Kuopio Epilepsy Center, Department of Neurology, Kuopio University Hospital, Kuopio, Finland
    Epilepsy Behav 8:750-5. 2006
    ..The results of this small open-label extension study indicate that patients with chronic partial epilepsy who were successfully converted to long-term tiagabine monotherapy demonstrated no adverse effects on cognitive function or mood...
  14. ncbi Motor cortical plasticity is impaired in Unverricht-Lundborg disease
    Nils Danner
    Department of Clinical Neurophysiology, Kuopio University Hospital, Kuopio, Finland
    Mov Disord 26:2095-100. 2011
    ..The impaired cortical plasticity may be associated with the previously reported structural and physiological abnormalities of the primary motor cortex...
  15. ncbi Non-invasive preoperative localization of primary motor cortex in epilepsy surgery by navigated transcranial magnetic stimulation
    Laura Säisänen
    Department of Clinical Neurophysiology, Kuopio University Hospital, Kuopio, Finland
    Epilepsy Res 92:134-44. 2010
    ..Navigated transcranial magnetic stimulation (nTMS) is a non-invasive method to localize the primary motor cortex (M1)...
  16. ncbi Increased expression of caspase 2 in experimental and human temporal lobe epilepsy
    Susanna Narkilahti
    A I Virtanen Institute for Molecular Sciences, University of Kuopio, and Department of Neurology, Kuopio University Hospital, Finland
    Neuromolecular Med 9:129-44. 2007
    ..Our data suggest that caspase 2-mediated programmed cell death participates in the seizure-induced degenerative process in experimental and human TLE...
  17. ncbi Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene
    Päivi Koskenkorva
    Department of Clinical Radiology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland
    Neurodegener Dis 8:515-22. 2011
    ..We describe the clinical, cognitive and imaging characteristics of 5 Finnish EPM1 patients who are compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutations...
  18. ncbi The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children
    Katriina Viinikainen
    Kuopio Epilepsy Center, Department of Neurology, Kuopio University Hospital and University of Kuopio, POB 1777, 70211, Kuopio, Finland
    Epilepsy Behav 9:636-40. 2006
    ..Larger studies with a prospective design are needed to confirm these findings...
  19. ncbi Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy
    Arto Immonen
    Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 51:2260-9. 2010
    ..The purpose of this study was to determine the long-term outcomes of consecutive true MRI-negative TLE patients who all underwent standardized preoperative evaluation with intracranial electroencephalography (EEG) electrodes...
  20. ncbi Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1)
    Nils Danner
    Department of Clinical Neurophysiology, Institute of Clinical Medicine, School of Medicine, University of Eastern Finland and Kuopio University Hospital, POB 1777, FIN 70211 Kuopio, Finland
    Seizure 20:65-71. 2011
    ..202C>T mutation in the CSTB gene (chEPM1). There are no previous clinical or neurophysiological studies on these patients. Thus, we aimed to characterize possible functional alterations in primary motor cortical areas...
  21. ncbi Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?
    Tadeusz Musialowicz
    Department of Anesthesiology and Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland
    Epilepsia 51:1580-6. 2010
    ..We conducted a study to evaluate the feasibility of using the BIS monitoring to assess the burst suppression (BS) pattern during propofol anesthesia in RSE...
  22. ncbi Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy
    Iiris Sorri
    Department of Ophthalmology, Kuopio University Hospital, P O Box 1777, FIN 70211 Kuopio, Finland Department of Ophthalmology, University of Kuopio, Kuopio, Finland
    Epilepsy Res 67:101-7. 2005
    ..Contrast sensitivity function was within normal ranges. The present study suggests that AED therapy with tiagabine, like with other established and newer AEDs may interfere with color perception...
  23. ncbi Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1)
    Nils Danner
    Department of Clinical Neurophysiology, Kuopio University Hospital and University of Kuopio, POB 1777, Kuopio FI 70211, Finland
    Epilepsy Res 85:81-8. 2009
    ..The aim of this study was to assess the function of the motor cortex in Unverricht-Lundborg disease (ULD), progressive myoclonus epilepsy type 1 (EPM1)...
  24. ncbi Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons
    Ilkka Parviainen
    Department of Anesthesiology and Intensive Care, Kuopio Epilepsy Center, Kuopio University Hospital, Kuopio, Finland
    Neurol Res 29:667-71. 2007
    ..To discuss mainly the use of propofol and barbiturates in the anesthesia of refractory status epilepticus (RSE)...
  25. ncbi Late-onset Rasmussen's encephalitis and long-term remission
    Laura Kupila
    Department of Neurology, Paijat Hame Central Hospital, LahtiDepartment of Neurology, Paijat Hame Central Hospital, Lahti, Finland
    Epileptic Disord 13:88-91. 2011
    ..To our knowledge, this is the first report of a patient with Rasmussen's encephalitis who has become completely symptomless, at least for three years, on enhanced antiepileptic and immunological medication...
  26. ncbi Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero
    Iiris Sorri
    Department of Ophthalmology, Kuopio University Hospital, P O Box 1777, FIN 70211 Kupio, Finland
    Epilepsy Res 65:117-20. 2005
    ..We explored ophthalmic and neurologic findings in two children who have been exposed prenatally to VGB...
  27. ncbi Thickened skull, scoliosis and other skeletal findings in Unverricht-Lundborg disease link cystatin B function to bone metabolism
    Sanna Suoranta
    Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland
    Bone 51:1016-24. 2012
    ..Cystatin B, cathepsin K, and altered osteoclast bone resorption activity are interconnected in vitro. This study evaluated the skeletal characteristics of patients with EPM1...
  28. ncbi The effect of fMRI task combinations on determining the hemispheric dominance of language functions
    Eini Niskanen
    Department of Applied Physics, University of Eastern Finland, Kuopio, Finland
    Neuroradiology 54:393-405. 2012
    ....
  29. ncbi Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
    Iiris Sorri
    Department of Ophthalmology, Kuopio University Hospital, P O Box 1777, FIN 70211 Kuopio, Finland
    Epilepsy Res 92:48-53. 2010
    ..Although the clinical and electrophysiological features of VFDs are well documented, the mechanism of retinal toxicity is still unclear...
  30. ncbi Propofol in the treatment of refractory status epilepticus
    Ilkka Parviainen
    Department of Anesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland
    Intensive Care Med 32:1075-9. 2006
    ..To study prospectively the effects of propofol anesthesia on seizure control, hemodynamics and course of intensive care in patients with refractory status epilepticus...
  31. ncbi More severe epilepsy and cognitive impairment in the offspring of a mother with mosaicism for the ring 20 chromosome
    Eila Herrgard
    Kuopio Epilepsy Center, FIN 70211 Kuopio, Finland
    Epilepsy Res 73:122-8. 2007
    ..Cases tend to be sporadic. We elucidate the characteristics of an inherited r(20) mosaicism by describing the clinical features of three family members: a mother and her two children...
  32. ncbi Visual function in epilepsy patients treated with initial valproate monotherapy
    Iiris Sorri
    Department of Ophthalmology, Kuopio University Hospital, FIN 70211 Kuopio, Finland
    Seizure 14:367-70. 2005
    ..To investigate whether initial valproate (VPA) monotherapy for the treatment of epilepsy causes visual field defects and visual dysfunction...
  33. ncbi Cystatin C expression is associated with granule cell dispersion in epilepsy
    Terhi J Pirttilä
    A I Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland
    Ann Neurol 58:211-23. 2005
    ....
  34. ncbi Infertility treatment and umbilical cord length-novel markers of childhood epilepsy?
    Sari Räisänen
    Department of Obstetrics and Gynaecology, Kuopio University Hospital, Kuopio, Finland
    PLoS ONE 8:e55394. 2013
    ..Epilepsy is one of the most common neurologic disorders of childhood, affecting about 0.4-0.8% of all children up to the age of 20...